会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • 9-DEOXO- 9A-METHYL- 9A- AZA- 9A-H0M0ERYTHR0MYCIN A DERIVATIVES FOR THE TREATMENT OF NEUTROPHIL DOMINATED INFLAMMATORY DISEASES
    • 9-去氧-9-9A-METHYL-9A-AZA-9A-H0MOERYTHROMYCIN用于治疗中性粒细胞性炎症性疾病的衍生物
    • WO2010086350A1
    • 2010-08-05
    • PCT/EP2010/050968
    • 2010-01-28
    • GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O.ALIHODZIC, SulejmanHUTINEC, AntunKOSTRUN, SanjaMATANOVIC SKUGOR, MajaPALEJ JAKPOVIC, Ivana
    • ALIHODZIC, SulejmanHUTINEC, AntunKOSTRUN, SanjaMATANOVIC SKUGOR, MajaPALEJ JAKPOVIC, Ivana
    • C07H17/00A61K31/7042A61P29/00
    • C07H17/00
    • 2'-0-substituted 14- or 15-membered azalide macrolides of Formula (I) wherein R 6 represents (i) -C 1-8 alkyl, unsubstituted or substituted at the terminal carbon atom by a group selected from hydroxy, -C 1-3 alkoxy and -C(O)OC 1-3 alkyl, or when -C 1-8 alkyl is branched, substitution can alternatively be by a hydroxyl group at each of two terminal carbon atoms, (ii) -CH(NH 2 )C 1-4 alkyl, wherein the -C 1-4 alkyl group may be optionally interrupted by a heteroatom selected from O, S and N, (iii) -CH 2 N(R 7 )(R 8 ), wherein R 7 and R 8 each independently represent H or -C 1-3 alkyl provided that R 7 and R 8 cannot both simultaneously represent H, (iv) a 4-6-membered heterocyclic ring containing up to 2 heteroatoms independently selected from O, S and N, wherein the heterocyclic ring is unsubstituted or substituted by -C 1-3 alkyl, (v) 5-6 membered heteroaromatic ring, unsubstituted or substituted by one to three groups independently selected from halo, hydroxyl, -C 1-3 alkyl, -C 1-3 alkoxy, -CF 3 , -OCF 3 and -NH 2 , (vi) -CH(NH 2 )CH 2 -aryl wherein the aryl group may be unsubstituted or substituted by one or two substituents independently selected from -C 1-3 alkyl, -C 1-3 alkoxy and hydroxyl, (vii) -C 3-7 cycloalkyl, or (viii) phenyl unsubstituted or substituted by one or two groups independently selected from halo, hydroxyl, -C 1-3 alkyl, -C 1-3 alkoxy, -CF 3 , -OCF 3 and -NH 2 , or salts thereof, useful in the treatment of neutrophil dominated inflammatory diseases, especially in the treatment of neutrophil dominated inflammatory diseases resulting from neutrophilic infiltration and/or diseases associated with altered cellular functionality of neutrophils, to methods for their preparation, to their use as therapeutic agents, and to salts thereof.
    • (I)的2'-取代的14-或15-元氮杂大环内酯,其中R 6表示(i)-C 1〜C 8烷基,未被取代或在末端碳原子被选自羟基,-C 1-3烷氧基和 -C(O)OC 1-3烷基,或者当-C 1-8烷基支链时,取代可以是两个末端碳原子上的羟基,(ⅱ)-CH(NH 2)C 1-4烷基,其中-C 1 可以任选地被选自O,S和N的杂原子,(ⅲ)-CH 2 N(R 7)(R 8)中断,其中R 7和R 8各自独立地表示H或-C 1-3烷基,条件是R 7和R 8不能同时 同时表示H,(iv)含有至多2个独立地选自O,S和N的杂原子的4-6元杂环,其中杂环是未取代的或被-C 1-3烷基取代,(v)5-6元 未被取代或被一至三个独立地选自卤素,羟基,-C 1-3烷基,-C 1-3烷氧基,-CF 3,-OCF 3和-NH 2的基团取代的杂芳环,(vi) -CH(NH 2)CH 2 - 芳基,其中芳基可以是未取代的或被一个或两个独立地选自-C 1-3烷基,-C 1-3烷氧基和羟基的取代基取代,(vii)-C 3-7环烷基或(viii) 未被取代或被一个或两个独立地选自卤素,羟基,-C 1-3烷基,-C 1-3烷氧基,-CF 3,-OCF 3和-NH 2的基团或其盐,可用于治疗嗜中性粒细胞主导的炎性疾病,特别是 治疗由嗜中性粒细胞浸润引起的嗜中性粒细胞主导的炎性疾病和/或与嗜中性粒细胞的改变的细胞功能相关的疾病,其制备方法,其作为治疗剂的用途及其盐。